|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 89 No. 6 (March 15), 1997:
pp. 2060-2066
Phosphatidylserine Externalization Is a Downstream Event of Interleukin-1 -Converting Enzyme Family Protease Activation During Apoptosis
By
Mikihiko Naito,
Kimie Nagashima,
Tetsuo Mashima, and
Takashi Tsuruo
From the Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan; and the Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
 |
ABSTRACT |
Phosphatidylserine (PS), a class of acidic phospholipids, normally localizes on the internal surface of cellular plasma membranes. The internal PS is externalized when cells undergo apoptosis; however, the mechanism for this is largely unknown. To study the mechanism of PS externalization during development of apoptosis, we examined the correlation between the activation of interleukin-1 -converting enzyme (ICE) family protease and PS externalization in human monocytic leukemia U937 cells and in their apoptosis-resistant variants, UK711 and UK110, after treatment with etoposide and anti-Fas antibody. We found that PS externalization accompanied the development of apoptosis and the activation of ICE family proteases in these cell lines. Furthermore, inhibitors of ICE family proteases, Z-Asp and Z-VAD, prevented apoptosis and PS externalization in etoposide-treated U937 cells. These results indicate that PS externalization is a downstream event of ICE family protease activation during apoptosis development. Because ICE family proteases play a crucial role in apoptosis, PS externalization could be a rational and useful marker for the development of apoptosis.
| |
INTRODUCTION |
IN CELLULAR PLASMA membranes, phosphatidylserine (PS), a class of acidic phospholipids, is normally located on the internal leaflet of the lipid bilayer.1-4 The molecular mechanism of the asymmetric distribution of PS is not well understood, but it is assumed that a translocase specific to aminophospholipids, such as PS and phosphatidylethanolamine (PE), preferentially mediates translocation of PS from the outer to the inner leaflet in a pH-dependent manner.5-7 This results in the asymmetric distribution of PS and PE.
The interior PS is exposed to the external surface of the plasma membrane under some physiologic conditions. When platelets are activated, the phospholipid asymmetry is lost in the plasma membrane and PS is externalized.8,9 On the activated platelet membranes, a coagulation cascade is initiated by factor Va binding and the subsequent generation of prothrombinase activity by factor Xa binding, which depends on Ca2+ and the externalized PS.8,10 The externalized PS is also involved in cellular recognition by macrophages. Erythrocytes expose PS on their surfaces when they become senescent.11 PS is also exposed in some pathologic erythrocytes, eg, sickle cells.12 In addition, cells that undergo apoptosis were reported to expose PS on their surfaces.13-15 Macrophages recognize the PS externalized cells through a specific PS receptor, resulting in an accelerated engulfment.13,16-18 Thus, PS externalization is a physiologically important phenomena, although the molecular mechanism is largely unknown.
Apoptosis is a physiologic process by which cells undergo controlled cell death accompanied by nuclear condensation and fragmentation before loss of membrane integrity.19,20 In a hematopoietic system, apoptosis is generally observed during the development of lymphocytes and neutrophils21 and when neoplastic cells are treated with antitumor drugs.22,23 As of now, the molecular mechanism of apoptosis is not well understood, yet we know that interleukin-1-converting enzyme (ICE) family proteases play an important role in initiating apoptosis in a variety of cell systems because (1) ICE family proteases were activated during apoptosis,24-28 (2) overexpression of the proteases induced the cells to undergo apoptosis,29-36 and (3) inhibitors of ICE family proteases prevented apoptosis of the cells.24,25,37,38 Because PS was externalized in apoptotic cells,13-15 we hypothesized that the PS externalization is initiated by ICE family protease activation. The aim of this study is to clarify the relationship between PS externalization and ICE family protease activation during the development of apoptosis. In fact, we found that PS was externalized after the activation of ICE family protease during apoptosis of human monocytic leukemia cells.
| |
MATERIALS AND METHODS |
Materials.
Annexin V-fluorescein isothiocyanate (FITC) was purchased from Nexins Research B.V. (Maastricht, The Netherlands). Anti-CPP32 and anti-Fas (clone CH-11) monoclonal antibodies were from Transduction Laboratories (Lexington, KY) and MBL (Nagoya, Japan), respectively. Etoposide was kindly provided by Bristol Meyers-Squibb (Tokyo, Japan). Benzyloxycarbonyl-Asp-CH2OC(O)-2,6-dichlorobenzene (Z-Asp) and benzyloxycarbonyl-Val-Ala-Asp-CH2OC(O)-2,6-dichlorobenzene (Z-VAD) were generous gifts from Dr H. Kawai (Kirin Brewery, Takasaki, Japan).
Cell lines and cell culture.
Human monocytic leukemia U937 cells were obtained from the Japanese Cancer Research Resources Bank (Tokyo, Japan). Apoptosis-resistant variants of U937 cells, UK71139 and UK110,40,41 were isolated in our laboratory. The cells were grown in RPMI 1640 medium (Nissui Co, Ltd, Tokyo, Japan) supplemented with 10% heat-inactivated fetal bovine serum and 100 µg/mL kanamycin in a humidified atmosphere of 5% CO2 and 95% air at 37°C. All of the experiments were performed using cells in their exponential growth phase and were repeated at least three times.
Measurement of apoptosis by flow cytometer.
Cells (5 × 105 cells/mL) were treated with the indicated concentrations of etoposide or anti-Fas antibody for 4 hours. After incubation, 5 × 105 cells were harvested, washed in ice-cold phosphate-buffered saline, and fixed in 70% ethanol for 30 minutes on ice. The cells were then washed, treated with 1 mg/mL RNase A for 1 hour at 37°C, and stained in propidium iodide solution (50 µg/mL in 0.1% sodium citrate, 0.1% NP-40). The stained cells were analyzed in a FACScan flow cytometer (Becton Dickinson, Braintree, MA).
Measurement of PS externalization by annexin V binding.
After treatments, 2 × 105 cells were harvested, washed in ice-cold phosphate-buffered saline, and resuspended in 200 µL of annexin binding buffer (10 mmol/L HEPES, pH 7.4, 150 mmol/L NaCl, 5 mmol/L KCl, 1 mmol/L MgCl2 , and 2 mmol/L CaCl2 ). The cells were stained with annexin V-FITC for 10 minutes on ice in the dark, according to the manufacturer's instructions, and analyzed in a FACScan flow cytometer.
Immunoblot analysis.
The treated cells (1.5 × 106 cells) were harvested, washed, and solubilized in 50 µL of lysis buffer (25 mmol/L Tris-HCl, pH 7.5, 50 mmol/L NaCl, 2% NP-40, 0.5% sodium deoxycholate, 0.2% sodium dodecyl sulfate [SDS], 1 mmol/L phenylmethylsulfonyl fluoride, 0.1 U/mL aprotinin, and 4 mmol/L iodoacetamide) for 15 minutes on ice. After centrifugation, the supernatants were collected as cell lysates. The protein concentration was determined using BCA protein assay reagents (Pierce, Rockford, IL). The cell lysates (20 µg/lane) were subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and electroblotted onto a nitrocellulose membrane. Immunoblot analysis of CPP32 was performed according to the manufacturer's instruction, and the protein bands were detected using enhanced chemiluminescence (ECL) reagents exposed to reflection autoradiography film (Du Pont-NEN, Boston, MA).
Actin cleavage assay.
Actin cleavage activity was measured as described previously.26 Briefly, biotinylated actin (0.2 µg/assay) was incubated with cytosolic fractions from U937, UK711, and UK110 cells for 2 hours. The reaction mixtures were separated by 15%/25% gradient polyacrylamide gel (Daiichi Chemical, Tokyo, Japan) and transblotted onto a nitrocellulose membrane, and the biotinylated proteins were detected with peroxidase-conjugated avidin and ECL reagent.
| |
RESULTS |
PS externalization during apoptosis.
Human monocytic leukemia U937 cells underwent apoptosis when cells were treated with 10 µg/mL of etoposide, an inhibitor of DNA topoisomerase II with prominent antitumor activity. Figure 1A shows the flow cytometric analysis of the etoposide-treated cells after staining DNA with propidium iodide. Apoptotic cells with DNA content less than G1 dramatically increased at 3 and 4 hours after drug treatment (Fig 1A). PS externalization was measured using FITC-labeled annexin V,14,15 which specifically binds to PS in the presence of Ca2+. As shown in Fig 1B, annexin-positive cells also appeared at 3 and 4 hours after etoposide treatment. Because more than 90% of the apoptotic cells maintained plasma membrane integrity as determined by dye exclusion test (not shown), annexin V bound to the externalized PS on these cells.
View larger version (14K):
[in this window]
[in a new window]
| Fig 2.
Time course of apoptosis and PS externalization in U937 cells. U937 cells were treated with 1 (circles), 3 (squares), and 10 (triangles) µg/mL etoposide for the indicated times. After the treatments, the development of apoptosis (open symbols) and PS externalization (solid symbols) were analyzed using a flow cytometer, as described in the Materials and Methods. The results are representative of three independent experiments.
|
|
View larger version (18K):
[in this window]
[in a new window]
View larger version (20K):
[in this window]
[in a new window]
View larger version (47K):
[in this window]
[in a new window]
View larger version (32K):
[in this window]
[in a new window]
| Fig 3.
Correlation of (A) apoptosis, (B) PS externalization, and (C) ICE family protease activation determined by actin cleavage assay and (D) CPP32 processing in U937 and its apoptosis-resistant variant cell lines, UK711 and UK110. Cells were treated without (C) or with 10 µg/mL VP16 (V) or 150 ng/mL anti-Fas antibody and 1 µg/mL cycloheximide (F ) for 4 hours. Numbers in parentheses in (A) and (B) are the percentages of apoptotic cells and PS externalized cells, respectively. The experiments were repeated four times and similar results were obtained.
|
|
From the histograms of the flow cytometric analysis, we quantitated percentages of apoptotic cells and PS externalized cells (Fig 2). When U937 cells were treated with 10 and 3 µg/mL of etoposide, the populations of PS externalized cells and apoptotic cells rapidly increased after 3 and 4 hours of drug treatment, respectively. The PS externalization and the apoptosis were observed to occur more slowly when cells were treated with 1 µg/mL etoposide. In all cases, PS externalization accompanied the progression of apoptosis in the etoposide-treated U937 cells.
PS externalization and ICE family protease activation in U937 cells and their apoptosis-resistant variants.
To study the relationship between PS externalization and ICE family protease activation during apoptosis, we induced apoptosis with etoposide and anti-Fas antibody in U937 cells and their apoptosis-resistant variant cell lines UK711 and UK110. In U937 cells, both anti-Fas antibody and etoposide induced apoptosis (Fig 3A) and PS externalization (Fig 3B). Enzyme activity that cleaves actin to generate a 15-kD fragment by an ICE family protease26 appeared in the cytosolic fractions of these apoptotic cells (Fig 3C). CPP32, an ICE family protease involved in apoptosis of U937 cells,41 was consistently processed to the p17 fragment (Fig 3D), indicating that CPP32 was activated by etoposide and anti-Fas antibody treatment in U937 cells.
In UK711 cells, which show resistance to etoposide-induced apoptosis but not to anti-Fas antibody-induced apoptosis (Fig 3A),39 PS was externalized only after anti-Fas antibody treatment (Fig 3B). The anti-Fas antibody treatment induced the actin cleavage activity (Fig 3C) and the processing of CPP32 (Fig 3D) in UK711 cells, whereas etoposide caused neither. Conversely, etoposide could induce apoptosis (Fig 3A), PS externalization (Fig 3B), actin cleavage activity (Fig 3C), and CPP32 processing (Fig 3D) in another apoptosis-resistant variant, UK110, which shows selective resistance to Fas-mediated and p55-TNFR-mediated apoptosis.40,41 Anti-Fas antibody caused all of the apoptotic features in significantly reduced levels in the UK110 cells. These results indicate that PS externalization correlates well with the activation of ICE family proteases during apoptosis.
Inhibition of PS externalization by inhibitors of ICE family proteases.
To study further the relationship between PS externalization and ICE family protease activation, we examined the effect of Z-Asp and Z-VAD, inhibitors of ICE family proteases,37,42 on PS externalization. When U937 cells were treated with etoposide in the presence of graded concentrations of Z-Asp, morphologic apoptosis was blocked in a dose-dependent manner. Z-Asp at 100 µg/mL completely inhibited PS externalization, but at less than 30 µg/mL, it could not inhibit PS externalization (Fig 4A). In the presence of 100 µg/mL Z-Asp, CPP32 was processed to the p20 fragment, but further processing to the p17 fragment was completely inhibited (Fig 4B). Z-Asp at 30 and 10 µg/mL partially inhibited the processing from the p20 to the p17 fragment.
View larger version (20K):
[in this window]
[in a new window]
View larger version (28K):
[in this window]
[in a new window]
| Fig 4.
Inhibition of apoptosis, PS externalization, and CPP32 processing by inhibitors of ICE family proteases. U937 cells were treated with 10 µg/mL etoposide in the presence of indicated concentrations of Z-Asp (circles) and Z-VAD (squares) for 4 hours. The development of apoptosis (open symbols) and PS externalization (solid symbols) were analyzed using a flow cytometer (A), and CPP32 processing was examined by Western blot analysis (B). CPP32 processing to the p20 and p17 fragments is presented. Lane 1, no inhibitor; lanes 2 through 4, Z-Asp at 10, 30, and 100 µg/mL, respectively; lanes 5 through 7, Z-VAD at 10, 30, and 100 µg/mL, respectively. The experiments were repeated three times and similar results were obtained.
|
|
Z-VAD was a more potent inhibitor of apoptosis than Z-Asp, and it inhibited morphologic apoptosis efficiently even at 10 µg/mL (Fig 4A). However, PS externalization was not effectively inhibited at 10 µg/mL. Z-VAD at 30 and 100 µg/mL effectively inhibited the PS externalization. Again, CPP32 was processed to the p20 fragment but not to the p17 fragment in the presence of Z-VAD at 30 and 100 µg/mL (Fig 4B). The PS externalization and CPP32 processing to p17 fragment were inhibited by 100 µg/mL Z-VAD for longer time periods up to 9 hours (data not shown).
| |
DISCUSSION |
We showed that PS was externalized on the plasma membrane when ICE family proteases were activated in the cells irrespective of the sensitivity to etoposide- and Fas-induced apoptosis. Inhibitors of the ICE family proteases, Z-Asp and Z-VAD, prevented apoptosis and PS externalization. These results indicate that PS is externalized after the ICE family protease activation during apoptosis of U937 cells. Notably, PS externalization was observed in the presence of low concentrations of ICE family protease inhibitors, by which morphologic apoptosis was effectively prevented and CPP32 processing to the p17 fragment was partially inhibited. Although the protease responsible for CPP32 processing is as yet unidentified, an ICE family protease is likely to process the p20 to the p17 fragment. These results suggest that PS externalization is more sensitive to ICE family protease activation than are apoptotic morphologic changes. Because the activation of ICE family protease is a crucial event for apoptosis in a variety of cell systems,24-38,43 PS externalization could be a rational and useful indicator of apoptosis. However, results should be carefully interpreted because PS is also externalized when platelets and erythrocytes are activated by calcium ionophore A23187.44,45 Furthermore, erythrocytes from pathologic patients with diabetes46 and chronic myeloid leukemia47 expose PS on their surfaces. Thus, PS externalization could also occur independently of apoptosis.
The mechanism of PS externalization after activation of ICE family protease is not yet clear. The asymmetric distribution of PS is attributed to a translocase specific to aminophospholipids,5-7 which translocates PS and, less effectively, PE from the outer to the inner leaflet of the plasma membranes. Because the charged lipids generally exhibit a slow passive transmembrane diffusion,3 inactivation of the aminophospholipid translocase cannot explain the rapid PS externalization during apoptosis. Recently, it was suggested that downregulation of the aminophospholipid translocase and activation of a nonspecific scramblase were both responsible for PS externalization in T lymphocytes undergoing apoptosis.48 It is possible that these enzymes are processed by an activated ICE family protease during apoptosis.
Recently, several ICE family proteases have been isolated that could be involved in apoptosis.24,29,31-36,38,49 The activation mechanism of ICE family proteases has not been fully elucidated, but it is suggested that a family member (ICE) activates another member (CPP32) in some cells.50 Thus, sequential proteolytic activation was assumed in the ICE family proteases during apoptosis. However, in U937 cells, ICE is not activated during etoposide- and Fas-induced apoptosis,26 indicating that another protease is responsible for CPP32 activation in this cell line. Interestingly, precursor CPP32 was processed to the p20 fragment but not to the p17 fragment in the presence of ICE family protease inhibitors in U937 cells (Fig 4B). This result suggests that CPP32 is processed by at least two steps in this cell line. First, precursor CPP32 is cleaved to p20 (and probably p12) by a protease unaffected by the presence of Z-Asp and Z-VAD; subsequently, the p20 is further processed to the p17 by an ICE family protease inhibitable by Z-Asp and Z-VAD. As of now, the proteases responsible for CPP32 processing in U937 cells have not been determined. Further studies are needed to clarify the mechanism of ICE family protease activation and subsequent PS externalization.
| |
FOOTNOTES |
Submitted July 1, 1996;
accepted October 28, 1996.
Supported by a special grant for Advanced Research on Cancer and Grants-in-Aid for Cancer Research and Scientific Research from the Ministry of Education, Science and Culture, Japan.
Address reprint requests to Takashi Tsuruo, PhD, Institute of Molecular and Cellular Biosciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113, Japan.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be hearly marked
``advertisment'' in accordance with 18 U.S.C. section 1734 solely to
indicate this fact.
| |
ACKNOWLEDGMENT |
We are grateful to Drs A. Tomida and N. Fujita for helpful discussions. We also thank Drs H. Kawai and S. Kataoka for generous gifts of ICE family protease inhibitors.
| |
REFERENCES |
1.
Op den Kamp JAF:
Lipid asymmetry in membranes.
Annu Rev Biochem
48:47,
1979[Medline]
[Order article via Infotrieve]
2.
Devaux PF:
Protein involvement in transmembrane lipid asymmetry.
Annu Rev Biophys Biomol Struct
21:417,
1992[Medline]
[Order article via Infotrieve]
3.
Zachowski A:
Phospholipids in animal eukaryotic membranes: Transverse asymmetry and movement.
Biochem J
294:1,
1993
4.
Williamson P,
Schlegel RA:
Back and forth: The regulation and function of transbilayer phospholipid movement in eukaryotic cells (Review).
Mol Membr Biol
11:199,
1994[Medline]
[Order article via Infotrieve]
5.
Seigneuret M,
Devaux PF:
ATP-dependent asymmetric distribution of spin-labelled phospholipids in the erythrocyte membrane: Relation to shape change.
Proc Natl Acad Sci USA
81:3751,
1984[Abstract/Free Full Text]
6.
Auland ME,
Roufogalis BD,
Devaux PF,
Zachowski A:
Reconstitution of ATP-dependent aminophospholipid translocation in proteoliposomes.
Proc Natl Acad Sci USA
91:10938,
1994[Abstract/Free Full Text]
7.
Zachowski A,
Favre E,
Cribier S,
Herve P,
Devaux PF:
Outside-inside translocation of aminophospholipids in the human erythrocyte membrane is mediated by a specific enzyme.
Biochemistry
25:2585,
1986[Medline]
[Order article via Infotrieve]
8.
Bevers EM,
Comfurius EP,
van Rijn J,
Hemker C,
Zwaal RFA:
Generation of prothrombin-converting activity and exposure of phosphatidylserine at the outer surface of platelets.
Eur J Biochem
122:429,
1982[Medline]
[Order article via Infotrieve]
9.
Bevers EM,
Comfurius EP,
Zwaal RFA:
Changes in membrane phospholipid distribution during platelet activation.
Biochim Biophys Acta
736:57,
1983[Medline]
[Order article via Infotrieve]
10.
Rosing J,
Tans G,
Govers-Riemslag JWP,
Zwaal RFA,
Hemker HC:
The role of phospholipids and factor Va in the prothrombinase complex.
J Biol Chem
255:274,
1980[Abstract/Free Full Text]
11.
Connor J,
Pak CC,
Schroit AJ:
Exposure of phosphatidylserine in the outer leaflet of human red blood cells  Relationship to cell density, cell age and clearance by mononuclear cells.
J Biol Chem
269:2399,
1993[Abstract/Free Full Text]
12.
Blumenfeld N,
Zachowski A,
Galacteros F,
Beuzard Y,
Devaux PF:
Transmembrane mobility of phospholipids in sickle erythrocytes: Effect of deoxygenation on diffusion and asymmetry.
Blood
77:849,
1991[Abstract/Free Full Text]
13.
Fadok VA,
Voelker DR,
Campbell PA,
Cohen JJ,
Bratton DL,
Henson PM:
Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages.
J Immunol
148:2207,
1992[Abstract]
14.
Martin S,
Reutelingsperger CPM,
McGahon AJ,
Rader JA,
van Schie RCAA,
LaFace DM,
Green DR:
Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl.
J Exp Med
182:1545,
1995[Abstract/Free Full Text]
15.
Koopman G,
Reutelingsperger CP,
Kuijten GA,
Keehnen RM,
Pals ST,
van Oers MH:
Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis.
Blood
84:1415,
1994[Abstract/Free Full Text]
16.
Tanaka Y,
Scroit AJ:
Insertion of fluorescent phosphatidylserine into the plasma membrane of red blood cells: Recognition by autologous macrophages.
J Biol Chem
258:11335,
1983[Abstract/Free Full Text]
17.
Schroit AJ,
Madsen JM,
Tanaka Y:
In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes.
J Biol Chem
260:5131,
1985[Abstract/Free Full Text]
18.
Fukazawa M,
Adachi H,
Hirota K,
Tsujimoto M,
Arai H,
Inoue K:
SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells.
Exp Cell Res
222:246,
1996[Medline]
[Order article via Infotrieve]
19.
Duvall E,
Wyllie AH:
Death and the cell.
Immunol Today
7:115,
1986
20.
Steller H:
Mechanism and genes of cellular suicide.
Science
267:1445,
1995[Abstract/Free Full Text]
21.
Cohen JJ,
Duke RC,
Fadok VA,
Sellins KS:
Apoptosis and programmed cell death in immunity.
Annu Rev Immunol
10:267,
1992[Medline]
[Order article via Infotrieve]
22.
Thompson CB:
Apoptosis in the pathogenesis and treatment of disease.
Science
267:1456,
1995[Abstract/Free Full Text]
23.
Fisher DE:
Apoptosis in cancer therapy: Crossing the threshold.
Cell
78:539,
1994[Medline]
[Order article via Infotrieve]
24.
Nicholson DW,
Ali A,
Thornberry NA,
Vaillancourt JP,
Ding CK,
Gallant M,
Gareau Y,
Griffin PR,
Labelle M,
Lazebnik YA,
Munday NA,
Raju SM,
Smulson ME,
Yamin T-T,
Yu VL,
Miller DK:
Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.
Nature
376:37,
1995[Medline]
[Order article via Infotrieve]
25.
Miura M,
Friedlander RM,
Yuan J:
Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway.
Proc Natl Acad Sci USA
92:8318,
1995[Abstract/Free Full Text]
26.
Mashima T,
Naito M,
Fujita N,
Noguchi K,
Tsuruo T:
Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis.
Biochem Biophys Res Commun
217:1185,
1995[Medline]
[Order article via Infotrieve]
27.
Los M,
Van de Craen M,
Penning LC,
Schenk H,
Westendorp M,
Baeuerle PA,
Droge W,
Krammer PH,
Fiers W,
Schulze-Osthoff K:
Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis.
Nature
375:81,
1995[Medline]
[Order article via Infotrieve]
28.
Enari M,
Hug H,
Nagata S:
Involvement of an ICE-like protease in Fas-mediated apoptosis.
Nature
375:78,
1995[Medline]
[Order article via Infotrieve]
29.
Fernandes-Alnemri T,
Litwack G,
Alnemri ES:
CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme.
J Biol Chem
269:30761,
1994[Abstract/Free Full Text]
30.
Miura M,
Zhu H,
Rotello R,
Hartwieg EA,
Yuan J:
Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3.
Cell
75:653,
1993[Medline]
[Order article via Infotrieve]
31.
Kumar S,
Kinoshita M,
Noda M,
Copeland NG,
Jenkins NA:
Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme.
Genes Dev
8:1613,
1994[Abstract/Free Full Text]
32.
Munday NA,
Vaillancourt JP,
Ali A,
Casano FJ,
Miller DK,
Molineaux SM,
Yamin TT,
Yu VL,
Nicholson DW:
Molecular cloning and pro-apoptotic activity of ICErelII and ICErelIII, members of the ICE/CED-3 family of cysteine proteases.
J Biol Chem
270:15870,
1995[Abstract/Free Full Text]
33.
Kamens J,
Paskind M,
Hugunin M,
Talanian RV,
Allen H,
Banach D,
Bump N,
Hackett M,
Johnston CG,
Li P:
Identification and characterization of ICH-2, a novel member of the interleukin-1 beta-converting enzyme family of cysteine proteases.
J Biol Chem
270:15250,
1995[Abstract/Free Full Text]
34.
Fernandes-Alnemri T,
Litwack G,
Alnemri ES:
Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family.
Cancer Res
55:2737,
1995[Abstract/Free Full Text]
35.
Faucheu C,
Diu A,
Chan AW,
Blanchet AM,
Miossec C,
Herve F,
Collard-Dutilleul V,
Gu Y,
Aldape RA,
Lippke JA:
A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells.
EMBO J
14:1914,
1995[Medline]
[Order article via Infotrieve]
36.
Alnemri ES,
Fernandes-Alnemri T,
Litwack G:
Cloning and expression of four novel isoforms of human interleukin-1 beta converting enzyme with different apoptotic activities.
J Biol Chem
270:4312,
1995[Abstract/Free Full Text]
37.
Mashima T,
Naito M,
Kataoka S,
Kawai H,
Tsuruo T:
Aspartate-based inhibitor of interleukin-1-converting enzyme prevent antitumor agent-induced apoptosis in human myeloid leukemia U937 cells.
Biochem Biophys Res Commun
209:907,
1995[Medline]
[Order article via Infotrieve]
38.
Tewari M,
Quan LT,
O'Rourke K,
Desnoyers S,
Zeng Z,
Beidler DR,
Poirier GG,
Salvesen GS,
Dixit VM:
Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase.
Cell
81:801,
1995[Medline]
[Order article via Infotrieve]
39.
Kataoka S,
Naito M,
Tomida A,
Tsuruo T:
Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells.
Exp Cell Res
215:199,
1994[Medline]
[Order article via Infotrieve]
40.
Noguchi K,
Naito M,
Kataoka S,
Yonehara S,
Tsuruo T:
A recessive mutant of the U937 cell line acquired resistance to anti-Fas and anti-p55 tumor necrosis factor receptor antibodies induced apoptosis.
Cell Growth Differ
6:1271,
1995[Abstract]
41. Noguchi K, Naito M, Kugou H, Oshimura M, Mashima T, Fujita N, Yonehara S, Tsuruo T: Chromosome 22 complements apoptosis in Fas- and TNF-resistant mutant UK110 cells. Oncogene (in press)
42.
Dolle RE,
Hoyer D,
Prasad CVC,
Schmidt SJ,
Helaszek CT,
Miller RE,
Ator MA:
P1 aspartate-based peptide a-((2,6-dichlorobenzoyl)oxy)methyl ketones as potent time-dependent inhibitors of interleukin-1-converting enzyme.
J Med Chem
37:563,
1994[Medline]
[Order article via Infotrieve]
43.
Kumar S:
ICE-like proteases in apoptosis.
Trends Biochem Sci
20:198,
1995[Medline]
[Order article via Infotrieve]
44.
Williamson P,
Kulick A,
Zachowski A,
Schlegel RA,
Devaux PF:
Ca2+ induces transbilayer redistribution of all major phospholipids in human erythrocytes.
Biochemistry
31:6355,
1992[Medline]
[Order article via Infotrieve]
45.
Gaffet P,
Bettache N,
Bienvenue A:
Transverse redistribution of phospholipids during human platelet activation: Evidence for a vectorial outflux specific to aminophospholipids.
Biochemistry
34:6762,
1995[Medline]
[Order article via Infotrieve]
46.
Wali RK,
Jaffe S,
Kumar D,
Kalra VK:
Alterations in organization of phospholipids in erythrocytes as factor in adherence to endothelial cells in diabetes mellitus.
Diabetes
37:104,
1988[Abstract]
47.
Kumar A,
Gupta CM:
Red cell membrane abnormalities in chronic myeloid leukemia.
Nature
303:632,
1983[Medline]
[Order article via Infotrieve]
48.
Verhoven B,
Schlegel RA,
Williamson P:
Mechanism of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes.
J Exp Med
182:1597,
1995[Abstract/Free Full Text]
49.
Schlegel J,
Peters I,
Orrenius S,
Miller DK,
Thornberry NA,
Yamin T-T,
Nicholson DW:
CPP32/apopain is a key interleukin 1 converting enzyme-like protease involved in Fas-mediated apoptosis.
J Biol Chem
271:1841,
1996[Abstract/Free Full Text]
50.
Enari M,
Talanian RV,
Wong WW,
Nagata S:
Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis.
Nature
380:723,
1996[Medline]
[Order article via Infotrieve]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
H. P. Dong, A. Holth, L. Kleinberg, M. G. Ruud, M. B. Elstrand, C. G. Trope, B. Davidson, and B. Risberg
Evaluation of Cell Surface Expression of Phosphatidylserine in Ovarian Carcinoma Effusions Using the Annexin-V/7-AAD Assay: Clinical Relevance and Comparison With Other Apoptosis Parameters
Am J Clin Pathol,
November 1, 2009;
132(5):
756 - 762.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Arokium, M. Kamata, and I. Chen
Virion-Associated Vpr of Human Immunodeficiency Virus Type 1 Triggers Activation of Apoptotic Events and Enhances Fas-Induced Apoptosis in Human T Cells
J. Virol.,
November 1, 2009;
83(21):
11283 - 11297.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Martin, N. Cagnon, O. Sabido, B. Sion, G. Grizard, P. Durand, and R. Levy
Kinetics of occurrence of some features of apoptosis during the cryopreservation process of bovine spermatozoa
Hum. Reprod.,
February 1, 2007;
22(2):
380 - 388.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Huppertz and J. C. P. Kingdom
Apoptosis in the Trophoblast--Role of Apoptosis in Placental Morphogenesis
Reproductive Sciences,
September 1, 2004;
11(6):
353 - 362.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. Martin, O. Sabido, P. Durand, and R. Levy
Cryopreservation Induces an Apoptosis-Like Mechanism in Bull Sperm
Biol Reprod,
July 1, 2004;
71(1):
28 - 37.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Miyazaki, F. Ishikawa, T. Fujikawa, S. Nagata, and K. Yamaguchi
Intraperitoneal Injection of Lipopolysaccharide Induces Dynamic Migration of Gr-1high Polymorphonuclear Neutrophils in the Murine Abdominal Cavity
Clin. Vaccine Immunol.,
May 1, 2004;
11(3):
452 - 457.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Post, P. D. Katsikis, J. F. Tait, S. M. Geaghan, H. W. Strauss, and F. G. Blankenberg
Imaging Cell Death with Radiolabeled Annexin V in an Experimental Model of Rheumatoid Arthritis
J. Nucl. Med.,
October 1, 2002;
43(10):
1359 - 1365.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-Y. Yang, H. Chuang, R.-F. Chen, and K. D. Yang
Reversible phosphatidylserine expression on blood granulocytes related to membrane perturbation but not DNA strand breaks
J. Leukoc. Biol.,
February 1, 2002;
71(2):
231 - 237.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. G. Blankenberg, L. Naumovski, J. F. Tait, A. M. Post, and H. W. Strauss
Imaging Cyclophosphamide-Induced Intramedullary Apoptosis in Rats Using 99mTc-Radiolabeled Annexin V
J. Nucl. Med.,
February 1, 2001;
42(2):
309 - 316.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
H. D'Arceuil, W. Rhine, A. de Crespigny, M. Yenari, J. F. Tait, W. H. Strauss, T. Engelhorn, A. Kastrup, M. Moseley, F. G. Blankenberg, et al.
99mTc Annexin V Imaging of Neonatal Hypoxic Brain Injury Editorial Comment
Stroke,
November 1, 2000;
31(11):
2692 - 2700.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Pootrakul, P. Sirankapracha, S. Hemsorach, W. Moungsub, R. Kumbunlue, A. Piangitjagum, P. Wasi, L. Ma, and S. L. Schrier
A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in Thai patients with thalassemia
Blood,
October 1, 2000;
96(7):
2606 - 2612.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Andersson, J. Sjöstrand, A. Petersen, A. K. S. Honarvar, and J.-O. Karlsson
Caspase and Proteasome Activity during Staurosporin-Induced Apoptosis in Lens Epithelial Cells
Invest. Ophthalmol. Vis. Sci.,
August 1, 2000;
41(9):
2623 - 2632.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
V. Terpstra, E. S. van Amersfoort, A. G. van Velzen, J. Kuiper, and T. J. C. van Berkel
Hepatic and Extrahepatic Scavenger Receptors : Function in Relation to Disease
Arterioscler Thromb Vasc Biol,
August 1, 2000;
20(8):
1860 - 1872.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Kluza, A. Lansiaux, N. Wattez, C. Mahieu, N. Osheroff, and C. Bailly
Apoptotic Response of HL-60 Human Leukemia Cells to the Antitumor Drug TAS-103
Cancer Res.,
August 1, 2000;
60(15):
4077 - 4084.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
U. A. Hirt, F. Gantner, and M. Leist
Phagocytosis of Nonapoptotic Cells Dying by Caspase- Independent Mechanisms
J. Immunol.,
June 15, 2000;
164(12):
6520 - 6529.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Sakamoto, T. Mashima, A. Kizaki, S. Dan, Y. Hashimoto, M. Naito, and T. Tsuruo
Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis
Blood,
May 15, 2000;
95(10):
3214 - 3218.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. P. Rogakou, W. Nieves-Neira, C. Boon, Y. Pommier, and W. M. Bonner
Initiation of DNA Fragmentation during Apoptosis Induces Phosphorylation of H2AX Histone at Serine 139
J. Biol. Chem.,
March 24, 2000;
275(13):
9390 - 9395.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B. Brown, M. C. H. Clarke, L. Magowan, H. Sanderson, and J. Savill
Constitutive Death of Platelets Leading to Scavenger Receptor-mediated Phagocytosis. A CASPASE-INDEPENDENT CELL CLEARANCE PROGRAM
J. Biol. Chem.,
February 25, 2000;
275(8):
5987 - 5996.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. de la Taille, M.-W. Chen, M. Burchardt, D. K. Chopin, and R. Buttyan
Apoptotic Conversion: Evidence for Exchange of Genetic Information between Prostate Cancer Cells Mediated by Apoptosis
Cancer Res.,
November 1, 1999;
59(21):
5461 - 5463.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Wettreich, A. Sebollela, M. A. Carvalho, S. P. Azevedo, R. Borojevic, S. T. Ferreira, and T. Coelho-Sampaio
Acidic pH Modulates the Interaction between Human Granulocyte-Macrophage Colony-stimulating Factor and Glycosaminoglycans
J. Biol. Chem.,
October 29, 1999;
274(44):
31468 - 31475.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Shcherbina and E. Remold-O'Donnell
Role of Caspase in a Subset of Human Platelet Activation Responses
Blood,
June 15, 1999;
93(12):
4222 - 4231.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Gidon-Jeangirard, B. Hugel, V. Holl, F. Toti, J.-L. Laplanche, D. Meyer, and J.-M. Freyssinet
Annexin V Delays Apoptosis While Exerting an External Constraint Preventing the Release of CD4+ and PrPc+ Membrane Particles in a Human T Lymphocyte Model
J. Immunol.,
May 15, 1999;
162(10):
5712 - 5718.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Warny and C. P. Kelly
Monocytic cell necrosis is mediated by potassium depletion and caspase-like proteases
Am J Physiol Cell Physiol,
March 1, 1999;
276(3):
C717 - C724.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Seimiya and T. Tsuruo
Functional Involvement of PTP-U2L in Apoptosis Subsequent to Terminal Differentiation of Monoblastoid Leukemia Cells
J. Biol. Chem.,
August 14, 1998;
273(33):
21187 - 21193.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. C. Franklin, S. Srikanth, and A. S. Kraft
Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis
PNAS,
March 17, 1998;
95(6):
3014 - 3019.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. Bratton, V. A. Fadok, D. A. Richter, J. M. Kailey, L. A. Guthrie, and P. M. Henson
Appearance of Phosphatidylserine on Apoptotic Cells Requires Calcium-mediated Nonspecific Flip-Flop and Is Enhanced by Loss of the Aminophospholipid Translocase
J. Biol. Chem.,
October 17, 1997;
272(42):
26159 - 26165.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
Abstract
Introduction
Abstract
